Clinical trials: GRIN-related Neurodevelopmental Disorder
GRIN-related Disorders, GRIN1
TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders
The goal of this clinical study is to find out whether L-serine dietary supplementation helps improve overall clinical functioning in children and young adults (2-30 years) with GRIN-related neurodevelopmental disorders…
- Conditions
- GRIN-related Disorders, GRIN1, GRIN2A, GRIN2B
- Trial name
- NCT07377032
- Testing
- L-serine
- Where
- 3 sites in France, Italy and 1 more
- Volunteers
- 40 people
- Sponsor
- Meyer Children's Hospital IRCCS
GRIN-related Neurodevelopmental Disorder
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
The Phase 3 portion of Study RAD-GRIN-101 is a multinational, multicenter, randomized, double-blind, placebo-controlled trial followed by an open-label extension to evaluate the efficacy and safety of radiprodil in participants…
- Trial name
- NCT07224581
- Testing
- Radiprodil
- Where
- 34 sites in United States, Belgium and 8 more
- Volunteers
- 100 people
- Sponsor
- GRIN Therapeutics, Inc.